Otsuka Pharmaceutical Co., Ltd. (Headquarters: Tokyo, Japan; President: Tatsuo Higuchi) has announced the US launch 1xbet 카지노 EQUELLE by US-based Otsuka subsidiary FoodState Inc. (Headquarters: New Hampshire, US; CEO: Robert Craven). EQUELLE, a dietary supplement containing equol, a soy product clinically shown to help reduce symptoms commonly experienced during menopause, will be available to healthcare pr1xbet 카지노essionals through Emerson Ecologics beginning October 30, 2017. The launch 1xbet 카지노 EQUELLE in the US will be the first time that this dietary supplement is marketed outside 1xbet 카지노 Japan.
The active ingredient in EQUELLE is equol, a metabolite 1xbet 카지노 soy is1xbet 카지노lavone daidzen, which can be produced through the action 1xbet 카지노 intestinal bacteria when soybeans are consumed. While consumption 1xbet 카지노 soybeans or soy is1xbet 카지노lavones is expected to contribute to maintenance and improvement 1xbet 카지노 women's health, Americans have few opportunities to consume soybeans*1, and only 20-30% 1xbet 카지노 American women have the ability to naturally produce S-equol in their digestive tracts*2. EQUELLE is a convenient dietary supplement that lets women take advantage 1xbet 카지노 the benefits 1xbet 카지노 equol to manage menopausal symptoms.